Sun Pharma Hits 52-Week Low Amid US Tariff Threat
20
3
BTCCSquare news:
Sun Pharmaceutical Industries plunged to a 52-week low of ₹1,548, down 2.96%, as US President Trump's proposed 100% tariffs on branded pharmaceuticals rattled investor sentiment. Trading volumes surged with over 52 lakh shares changing hands, totaling ₹827.93 crore by midday.
Cipla showed relative resilience, slipping just 0.87% to ₹1,496.60, supported above its ₹1,475 threshold. Market experts note India's generic drug exports—constituting 85-90% of US-bound shipments—remain insulated from the tariffs. Companies like SUN Pharma and Cipla benefit from existing US manufacturing facilities, mitigating direct impact.
By:
